Neuroendocrine Prostate Cancer Market on Track for Transformative Growth by 2032 | DelveInsight
Leading companies like Amgen and BioXcel Therapeutics are spearheading advancements, redefining patient treatment possibilities. LAS VEGAS , NV, UNITED STATES, February 12, 2025 /EINPresswire.com/ -- DelveInsight’s “Neuroendocrine Prostate …